Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CPRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Catalyst Pharmaceuticals stock upgraded from Hold/Accumulate to Buy Candidate after Wednesday trading session.
(Updated on Mar 27, 2024)

Buy or Hold candidate since Mar 25, 2024 Gain 2.59% PDF

The Catalyst Pharmaceuticals stock price gained 3.30% on the last trading day (Wednesday, 27th Mar 2024), rising from $15.75 to $16.27. During the last trading day the stock fluctuated 4.88% from a day low at $15.89 to a day high of $16.67. The price has been going up and down for this period, and there has been a -2.11% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 521 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $21.43 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.78% during the next 3 months and, with a 90% probability hold a price between $14.43 and $18.29 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CPRX Signals & Forecast

The Catalyst Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $16.22 and $15.22. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -4.35%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Catalyst Pharmaceuticals stock

Catalyst Pharmaceuticals finds support from accumulated volume at $16.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.775 between high and low, or 4.88%. For the last week, the stock has had daily average volatility of 4.08%.

Our recommended stop-loss: $15.58 (-4.25%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 18 days ago.)

Trading Expectations (CPRX) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Catalyst Pharmaceuticals to open at $16.28, and during the day (based on 14 day Average True Range), to move between $15.61 and $16.93, which gives a possible trading interval of +/-$0.656 (+/-4.03%) up or down from last closing price. If Catalyst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 8.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $16.03 (1.48%) than the resistance at $16.62 (2.15%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Catalyst Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Catalyst Pharmaceuticals stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.239 Buy Candidate Upgraded

Predicted Opening Price for Catalyst Pharmaceuticals of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$16.28 ( 0.0307%) $16.27

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CPRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.05 4.79 %
R2 16.75 2.97 %
R1 16.57 1.85 %
Current price: 16.27
Support S1 15.98 -1.79 %
S2 15.80 -2.91 %
S3 15.50 -4.73 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 17.01 4.55 %
R2 16.69 2.58 %
R1 16.62 2.15 %
Current price 16.27
Support S1 16.03 -1.48%
S2 15.11 -7.13%
S3 14.57 -10.45%

FAQ

What is the symbol for Catalyst Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Catalyst Pharmaceuticals is CPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Catalyst Pharmaceuticals Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Catalyst Pharmaceuticals stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Catalyst Pharmaceuticals Stock?
Catalyst Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Catalyst Pharmaceuticals Stock.

What's the current price of Catalyst Pharmaceuticals Stock?
As of the end of day on the 2024-03-27, the price of an Catalyst Pharmaceuticals (CPRX) share was $16.27.

What is the 52-week high and low for Catalyst Pharmaceuticals Stock?
The 52-week high for Catalyst Pharmaceuticals Stock is $18.22 and the 52-week low is $11.09.

What is the market capitalization of Catalyst Pharmaceuticals Stock?
As of the 2024-03-27, the market capitalization of Catalyst Pharmaceuticals is 1.856B.

When is the next earnings date for Catalyst Pharmaceuticals?
The upcoming earnings date for Catalyst Pharmaceuticals is May 08, 2024.
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT